Senior Director, Clinical Development, Asia Pacific Lead, Rare Disease Therapeutic Area
Ipsen
·Today
- Location
- Shanghai, China
- Type
- Full-time
- Department
- IT
- Seniority
- Director
- Education
- PhD
- Source
- Workday
Description
Title:
Senior Director, Clinical Development, Asia Pacific Lead, Rare Disease Therapeutic AreaCompany:
Ipsen (shanghai) innovation pharmaceutical Co., Ltd.
About Ipsen:
Ipsen is a mid-sized global biopharmaceutical company with a focus on transformative medicines in three therapeutic areas: Oncology, Rare Disease and Neuroscience. Supported by nearly 100 years of development experience, with global hubs in the U.S., France and the U.K, we tackle areas of high unmet medical need through research and innovation.
Our passionate teams in more than 40 countries are focused on what matters and endeavor every day to bring medicines to patients in 88 countries. We build a workplace that champions human-centric leadership and fosters a culture of collaboration, excellence and impact. At Ipsen, every individual is empowered to be their true selves, grow and thrive alongside the company’s success. Join us on our journey towards sustainable growth, creating real impact on patients and society!
For more information, visit us at https://www.ipsen.com/ and follow our latest news on LinkedIn and Instagram.
Job Description:
The Senior Director, Clinical Development, Asia Pacific Lead, Rare Disease Therapeutic Area is the regional clinical development leader for Ipsen's Rare Disease portfolio across Asia Pacific. The role is responsible for translating global clinical development strategy into effective regional plans and execution, while ensuring that Asia-Pacific scientific, clinical, regulatory, operational and patient perspectives are incorporated into global development decisions.
Based in Shanghai, the role will work in close partnership with the co-located Regulatory Affairs and Clinical Operations teams, and in alignment with Global Asset Teams and global clinical development leaders. The position supports the full Rare Disease portfolio, currently spanning rare liver and rare renal diseases, and may contribute to additional Rare Disease programs as the portfolio evolves. The role will also provide clinical development support to global teams as needed.
Main Responsibilities & Technical Competencies:
Asia-Pacific clinical development leadership
· Lead the Asia-Pacific clinical development contribution across the Rare Disease portfolio, in alignment with the relevant Clinical Development Plans (CDPs), Integrated Development Plans (IDPs) and Target Product Profiles (TPPs).
· Translate global clinical strategy into fit-for-purpose regional development and execution plans, identifying where Asia-Pacific requirements, medical practice, epidemiology, standards of care, patient pathways and operational realities should shape global plans.
· Provide high-quality medical, scientific and strategic interpretation of regional data and the external environment to support development, registration, lifecycle management and evidence-generation decisions.
· Serve as the primary clinical lead for regulatory dossier preparation and response to questions and viewed as a subject medical expert.
· Serve as a senior clinical development partner to Global Asset Teams and study teams, representing Asia-Pacific perspectives and supporting global deliverables as needed.
· Identify and escalate critical regional risks, opportunities and decisions, with clear recommendations and actionable solutions.
Clinical program and study delivery
· Contribute to the design and delivery of CDPs and the clinical components of IDPs across rare liver and rare renal programs, and future Rare Disease assets assigned to the role.
· Lead or support development of study concepts, synopses, protocols, Investigator Brochures, clinical sections of regulatory submissions, clinical study reports and other key clinical documents; adapt global materials when required for regional use.
· Act as the clinical development decision-maker or regional clinical representative for assigned studies, partnering closely with Clinical Operations, Biostatistics, Data Management, Clinical Pharmacology, Safety and CRO partners.
· Provide or oversee medical monitoring activities, including oversight of external medical monitors where applicable, to support participant safety, data integrity and scientifically sound interpretation.
· Interpret emerging study results in the context of external evidence and the competitive landscape, and make clear development recommendations.
· Support post-approval commitments, registries, safety studies and other evidence-generation activities required by regional health authorities.
Shanghai and cross-functional partnership
· Work as an integrated partner with the Regulatory Affairs and Clinical Operations teams co-located in Shanghai, establishing clear accountabilities, rapid issue escalation and coordinated execution across the Asia-Pacific region.
· Partner with Regulatory Affairs on regional regulatory strategy, health-authority interactions, briefing documents, responses to questions and clinical content for submissions.
· Share responsibility with Clinical Operations for oversight of clinical trial execution, including quality, timelines, enrollment, budget awareness, site engagement and resolution of delivery risks.
· Collaborate across the global matrix with Global Patient Safety, Medical Affairs, HEOR, Commercial, Early Development, Clinical Pharmacology and other functions to ensure coherent regional and global plans.
· Support transformation, continuous improvement and a high-performance culture focused on patient impact, data quality, timeliness and disciplined execution.
External engagement and scientific leadership
· Build and maintain relationships with investigators, key external experts, patient-focused stakeholders and relevant scientific networks across Asia Pacific.
· Represent Ipsen, as appropriate, at investigator meetings, advisory boards, scientific congresses and interactions with health authorities.
· Contribute to abstracts, publications and presentations arising from Ipsen-sponsored studies.
· Maintain current knowledge of rare liver and renal diseases, regional clinical practice, relevant regulations and the evolving competitive landscape.
Portfolio and business development support
· Provide clinical development input on potential in-licensing, partnering and external innovation opportunities with relevance to Asia Pacific and the Rare Disease strategy.
· Contribute regional insights to portfolio prioritization, scenario planning, resource discussions and lifecycle opportunities.
Knowledge & Experience Required:
Essential
· Medical Doctor (MD), MBBS/MBChB or internationally equivalent medical degree. A PhD or equivalent life-sciences qualification may be considered where accompanied by substantial clinical development leadership experience.
· Significant pharmaceutical, biotechnology or CRO clinical development experience, with demonstrated responsibility for clinical programs or trials in a global matrix environment.
· Experience supporting drug development in Asia Pacific, including China, and working effectively with regional Regulatory Affairs and Clinical Operations colleagues.
· Demonstrated understanding of the clinical development value chain across early and late development, including study design, execution, data interpretation, regulatory interaction and evidence generation.
· Experience independently leading cross-functional projects and influencing senior stakeholders across functions, cultures and geographies.
· Strong scientific judgment, clear written and verbal communication, and the ability to translate complex information into decisions and action.
· Fluent English, spoken and written; ability to operate effectively in a multicultural environment.
· Willingness to travel domestically and internationally, as required for the role.
Preferred
· Clinical training in internal medicine, hepatology, nephrology, gastroenterology, pediatrics or another specialty relevant to Rare Disease development; board certification is advantageous.
· Experience in rare diseases and/or orphan drug development, particularly rare liver or rare renal diseases.
· Experience with global late-stage development, health-authority interactions, registration submissions or post-approval commitments.
· Knowledge of clinical development and regulatory requirements in China and other major Asia-Pacific markets.
· A record of scientific publications or presentations and an established external professional network.
· People leadership, mentoring or management experience.
· Mandarin language capability is advantageous for effective partnership in the Shanghai environment.
We are committed to creating a workplace where everyone feels heard, valued, and supported; where we embrace “The Real Us”. The value we place on different perspectives and experiences drives our commitment to inclusion and equal opportunities. When we include diverse ways of thinking, we make more thoughtful decisions and discover more innovative solutions. Together we strive to better understand the communities we serve. This means we also want to help you perform at your best when applying for a role with us. If you require any adjustments or support during the application process, please let the recruitment team know. This information will be handled with care and will not affect the outcome of your application.